Reversan
Reversan (CBLC4H10) is a dual inhibitor of MRP1 and P-glycoprotein (Pgp) that enhances chemotherapy efficacy in glioblastoma models. This non-toxic, highly effective small molecule is a valuable research tool for studying multidrug resistance in oncology, with applications in both in vitro and in vivo experimental systems.
Product Specifications
CAS Number
313397-13-6
Product Name Alternative
Multidrug resistance-associated protein 1, P-glycoprotein, CBLC 4H10, CBLC4H10, Reversan
Field of Research
Immunology & Inflammation, Neuroscience, Pharmacology & Drug Discovery
Purity
99.05% (May vary between batches)
Solubility
DMSO:10 mg/mL (22.65 mM)
Smiles
O=C (NCCCN1CCOCC1) C=2C=NN3C2N=C (C=C3C=4C=CC=CC4) C=5C=CC=CC5
Molecular Formula
C26H27N5O2
Molecular Weight
441.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
A2295-01W7 50 µg
Angiotensin Converting Enzyme 2, NT (ACE-2, ACEH) (Control Peptide)
Sign In for Pricing
View Details 